Trilogy ETF Growth
Trilogy Capital Expands Holdings, Significantly Boosting Stakes in Key Bond and Equity ETFs
Anonymous
Key Points
1
TLT position details: Trilogy Capital held 392,657 shares of iShares 20+ Year Treasury Bond ETF (TLT), about 1.5% of its portfolio and the 18th-largest holding, indicating a meaningful but not dominant exposure to long-duration Treasuries.
2
BND position: The Vanguard Total Bond Market ETF (BND) totals 739,826 shares, roughly 2.4% of Trilogy's portfolio, ranking as the 9th-largest holding with a value around $54.48 million.
3
SPSM move: Trilogy increased its SPDR Portfolio S&P 600 Small Cap ETF (SPSM) to 144,312 shares, worth about $6.97 million.
4
SPYV position: The SPDR Portfolio S&P 500 Value ETF (SPYV) holding rose to 137,135 shares, valued at about $7.76 million.
5
UCON stake: Trilogy increased its stake in First Trust TCW Unconstrained Plus Bond ETF (UCON) to 1,480,371 shares, approximately $36.67 million, about 1.6% of holdings and the 16th-largest position.
Trilogy Capital Inc. made a bold move into long-duration U.S. Treasury bonds in the first quarter of 2026, buying 94,178 additional shares of the iShares 20+ Year Treasury Bond ETF (TLT) — a 31.6% jump that brought its total to 392,657 shares worth about $34 million, according to Ticker Report. The California-based wealth manager, which oversees roughly $2.27 billion in assets, also expanded positions across four other major ETFs, signaling a deliberate shift toward fixed income and selective equity value plays.
The moves, disclosed in Trilogy's quarterly 13F filing with the SEC, paint a picture of a firm bracing for a slowing economy while still hunting for yield in targeted corners of the stock market, Watchlist News reported.
A Big Bet on Falling Long-Term Interest Rates
The 31.6% increase in TLT is the most striking move in Trilogy's Q1 filing. TLT tracks U.S. Treasury bonds with maturities of 20 years or more. When long-term interest rates fall, the value of those bonds rises — and TLT rises with them. By adding nearly 95,000 shares, Trilogy is clearly betting that rates will keep falling, according to Ticker Report.
TLT now ranks as Trilogy's 18th-largest holding, making up about 1.5% of its total portfolio. That is a meaningful position — but not a reckless one. The Federal Reserve had already cut rates by 175 basis points since late 2024, giving Trilogy reason to believe long-duration bonds still have room to run. BlackRock's Global Head of iShares Fixed Income ETFs, Stephen Laipply, described the current market as "the hunt for yield," noting that bond ETF inflows in 2026 were running 60% ahead of 2025 levels.
Bond ETFs Dominate Trilogy's Largest Holdings
Fixed income is clearly the backbone of Trilogy's strategy. The Vanguard Total Bond Market ETF (BND) remains its 9th-largest holding after a 3.1% increase to 739,826 shares, valued at roughly $54.5 million — about 2.4% of the total portfolio, per Watchlist News. BND holds thousands of U.S. bonds across all maturities, giving Trilogy broad, low-cost exposure to the entire bond market.
Trilogy also raised its stake in the First Trust TCW Unconstrained Plus Bond ETF (UCON) by 8.2%, reaching 1,480,371 shares worth about $36.7 million. UCON is an "unconstrained" fund — meaning its managers can buy almost any type of bond, not just those in a standard index. That flexibility makes it a higher-risk, higher-reward play compared to BND. Together, BND and UCON account for well over $90 million of Trilogy's portfolio.
Small-Cap and Value Stocks Get a Selective Boost
On the equity side, Trilogy made two targeted additions rather than chasing broad market gains. It raised its position in the SPDR Portfolio S&P 600 Small Cap ETF (SPSM) by 9.1% to 144,312 shares, worth about $6.97 million, according to Watchlist News. Small-cap stocks tend to benefit most when interest rates drop because smaller companies rely more on borrowing to grow.
Trilogy also lifted its SPDR Portfolio S&P 500 Value ETF (SPYV) position by 10.3% to 137,135 shares, valued at about $7.76 million. Value ETFs hold stocks that trade at low prices relative to their earnings — a deliberate contrast to momentum-driven growth funds chasing artificial intelligence stocks. The dual additions to SPSM and SPYV suggest Trilogy believes beaten-down and undervalued corners of the market are set to outperform in a slower-growth environment.
What This Strategy Signals for Trilogy's Clients
Analysts frame Trilogy's Q1 moves as a classic "defense-plus-income" playbook. By stacking BND, TLT, and UCON together, the firm is building a fixed-income wall that can generate steady monthly income — TLT alone paid roughly $0.34 per share monthly in Q1 — while cushioning clients against stock market drops. Trilogy manages wealth for a retail-focused client base, making capital preservation a top priority.
At the same time, the SPYV and SPSM additions show the firm is not purely defensive. It is making calculated, small-sized bets on value and small-cap recovery. None of the five ETF positions individually exceed 2.4% of the total portfolio. That tight sizing keeps risk contained while still positioning clients to gain if rates fall and undervalued stocks catch up.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
32
Articles
13
Reach
45
A
AnonymousAuthor
